1468-6708

Current Controlled Trials in Cardiovascular Medicine

Springer (Biomed Central Ltd.)

View prefix report (10.1186)

Health Score

0 Fair

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 90 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact90 DOIs
2

Add abstracts to 67 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact67 DOIs
3

Add license metadata to 4 records

License metadata tells indexers and readers how each article may be reused.

Low impact4 DOIs

DOIs for this ISSN

Showing the top 5 of 90 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Problems in dealing with missing data and informative censor… (10.1186/1468-6708-3-4)
Abstract ORCID
101.47 106
2 New insights into the effects on blood pressure of diets low… (10.1186/cvm-2-2-071)
Abstract ORCID License
92.28 16
3 The Carvedilol Prospective Randomized Cumulative Survival (C… (10.1186/cvm-2-1-020)
Abstract ORCID
92.25 69
4 Validation of Heart Failure Events in the Antihypertensive a… (10.1186/1468-6708-3-10)
Abstract ORCID
87.41 55
5 Pooling, meta-analysis, and the evaluation of drug safety (10.1186/1468-6708-3-6)
Abstract ORCID
77.82 35
6 Methodological considerations in the design of trials for sa… (10.1186/1468-6708-6-1)
Abstract ORCID
77.82 35
7 Use of diffusion and perfusion magnetic resonance imaging as… (10.1186/cvm-2-1-038)
Abstract ORCID
75.93 32
8 A Prospective Study of Pravastatin in the Elderly at Risk (P… (10.1186/1468-6708-3-8)
Abstract ORCID
73.12 28
9 Effects of a comprehensive cardiac rehabilitation program on… (10.1186/1468-6708-4-1)
Abstract ORCID
65.05 19
10 Informative noncompliance in endpoint trials (10.1186/1468-6708-5-5)
Abstract ORCID
63.94 18
11 Fundamental deficiencies in the megatrial methodology (10.1186/cvm-2-1-002)
Abstract ORCID
63.94 18
12 A randomized controlled trial of an extensive lifestyle mana… (10.1186/1468-6708-3-9)
Abstract ORCID
60.21 15
13 A Review of the Adverse Effects of Peripheral Alpha-1 Antago… (10.1186/1468-6708-3-7)
Abstract ORCID
58.80 14
14 Weight-modification trials in older adults: what should the… (10.1186/1468-6708-3-1)
Abstract ORCID
55.70 12
15 Carotid intimal-media thickness as a surrogate for cardiovas… (10.1186/1468-6708-6-3)
ORCID
54.97 157
16 Debate: does it matter how you lower blood pressure? (10.1186/cvm-2-2-063)
Abstract ORCID License
52.42 4
17 Long-term vitamin E supplementation fails to reduce lipid pe… (10.1186/1468-6708-3-5)
Abstract ORCID
50.00 9
18 New immunosuppressive drugs in heart transplantation (10.1186/cvm-2-1-045)
Abstract ORCID
50.00 9
19 Experience collecting interim data on mortality: an example… (10.1186/cvm-2-1-059)
Abstract ORCID
50.00 9
20 Effects of oral anticoagulation with various INR levels in d… (10.1186/1468-6708-5-1)
Abstract ORCID
47.71 8
21 Clinical significance of cardiovascular dysmetabolic syndrom… (10.1186/1468-6708-3-2)
Abstract ORCID
45.15 7
22 Effect of Omacor on HRV parameters in patients with recent u… (10.1186/1468-6708-4-2)
Abstract ORCID
45.15 7
23 Ablation of atrial fibrillation: a procedure come of age? (10.1186/cvm-2-2-067)
Abstract ORCID License
45.15 3
24 No effects on myocardial ischaemia in patients with stable i… (10.1186/cvm-2-2-099)
Abstract ORCID License
45.15 3
25 Effect of increased convective clearance by on-line hemodiaf… (10.1186/1468-6708-6-8)
ORCID
44.63 60
26 Effect of rosuvastatin on outcomes in chronic haemodialysis… (10.1186/1468-6708-6-9)
ORCID
42.69 50
27 Debate: "How low should LDL cholesterol be lowered?" Viewpoi… (10.1186/cvm-2-1-008)
Abstract ORCID
42.25 6
28 Enzyme estimates of infarct size correlate with functional a… (10.1186/1468-6708-6-12)
ORCID
39.21 36
29 Debate: "How low should LDL cholesterol be lowered for optim… (10.1186/cvm-2-1-012)
Abstract ORCID
38.91 5
30 Beyond the Evidence of the New Hypertension Guidelines. Bloo… (10.1186/1468-6708-6-6)
ORCID
36.56 28
31 The clopidogrel after surgery for coronary artery disease (C… (10.1186/1468-6708-6-15)
ORCID
36.18 27
32 Does the Angiotensin-converting enzyme (ACE) gene insertion/… (10.1186/1468-6708-6-16)
ORCID
35.37 25
33 The current status of primary prevention in coronary heart d… (10.1186/cvm-2-1-024)
Abstract ORCID
34.95 4
34 The SPHERE Study. Secondary prevention of heart disease in g… (10.1186/1468-6708-6-11)
ORCID
34.51 23
35 The Blood Pressure "Uncertainty Range" – a pragmatic approac… (10.1186/1468-6708-6-5)
ORCID
31.97 18
36 Equivalence and noninferiority trials – are they viable alte… (10.1186/1468-6708-5-8)
ORCID
31.38 17
37 Symptomatic relief precedes improvement of myocardial blood… (10.1186/1468-6708-6-7)
ORCID
31.38 17
38 The Myocardial Ischemia Reduction with Acute Cholesterol Low… (10.1186/1468-6708-3-3)
Abstract ORCID
30.10 3
39 Balancing commercial and public interests (10.1186/1468-6708-5-6)
Abstract ORCID
30.10 3
40 Are there fundamental deficiencies in the megatrial methodol… (10.1186/cvm-2-1-001)
Abstract ORCID
30.10 3
41 Elevated levels of matrix metalloprotein-3 in patients with… (10.1186/1468-6708-5-10)
ORCID
29.40 14
42 Compliance of a cobalt chromium coronary stent alloy – the C… (10.1186/1468-6708-6-17)
ORCID
26.98 11
43 A trial design for evaluation of empiric programming of impl… (10.1186/1468-6708-5-12)
ORCID
26.03 10
44 Fluvastatin in the therapy of acute coronary syndrome: Ratio… (10.1186/1468-6708-6-4)
ORCID
25.00 9
45 Anticoagulation for non-valvular atrial aibrillation – towar… (10.1186/1468-6708-5-3)
Abstract ORCID
23.86 2
46 Current trends in the cardiovascular clinical trial arena (I… (10.1186/1468-6708-5-4)
Abstract ORCID
23.86 2
47 Coronary artery bypass surgery in high-risk patients (10.1186/1468-6708-6-13)
ORCID
22.58 7
48 Exercise training improves aerobic endurance and musculoskel… (10.1186/1468-6708-6-10)
ORCID
21.13 6
49 Early and long-term outcome of elective stenting of the infa… (10.1186/1468-6708-5-11)
ORCID
19.45 5
50 A novel approach to treatment of hypertension in diabetic pa… (10.1186/1468-6708-5-9)
ORCID
19.45 5